Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

LCP2 antibody (AA 216-434)

LCP2 Reactivity: Human WB Host: Mouse Monoclonal SLP-76-03 unconjugated
Catalog No. ABIN1839588
  • Target See all LCP2 Antibodies
    LCP2 (Lymphocyte Cytosolic Protein 2 (SH2 Domain Containing Leukocyte Protein of 76kDa) (LCP2))
    Binding Specificity
    • 10
    • 4
    • 4
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 216-434
    Reactivity
    • 47
    • 24
    • 11
    • 3
    Human
    Host
    • 41
    • 7
    • 1
    Mouse
    Clonality
    • 43
    • 6
    Monoclonal
    Conjugate
    • 35
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    This LCP2 antibody is un-conjugated
    Application
    • 33
    • 12
    • 11
    • 7
    • 6
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    Western Blotting (WB)
    Specificity
    SLP-76 (SH2 domain-containing leukocyte protein) is an adaptor molecule that is involved in T cell development and activation. Thymocytes from transgenic mice expressing a SLP-76 mutant with deletion of the amino terminus are unable to develop to CD4-CD8- stage. Mature T cells do develop in mice expressing SLP-76 with mutations in proline rich region or SH2 domain, but they fail to upregulate CD69 or proliferate appropriately in response to anti-CD3 stimulation. SLP-76 is cytosolic protein identified as phosphoprotein migrating at 76 kD in SDS-PAGE. Amino-terminal domain of SLP-76 containing several tyrosines is followed by PR (proline rich) region and an SH2 domain. SLP-76 associates with LAT via Gads or Grb 2. The PR region of SLP-76 constitutively associates with carboxy-terminal SH3 domain of Gads and P-1 segment of the PR region was also identified that associates with the SH3 domain of PLC-gamma1. The PR region therefore provides another pathway for PLC-gamma1 recruitment to the LAT signalling complex in T cells. The SH2 domain of SLP-76 has been identified as the region involved in binding the serine/threonine kinase HPK1. HPK1 may act as both a positive and a negative regulator by promoting the Jnk mitogen activated protein kinase (MAPK) pathway and inhibiting the pathway leading to AP-1 activation.
    Purification
    Purified
    Immunogen
    A fusion protein representing amino acids 216-434 of human SLP-76.

    Type of Immunogen: Fusion protein
    Clone
    SLP-76-03
    Isotype
    IgG2b
    Top Product
    Discover our top product LCP2 Primary Antibody
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Comment

    Target Species of Antibody: Human

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    Lot specific
    Buffer
    PBS,  pH 7.4, 15 mM sodium azide
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handling Advice
    Avoid repeated freezing and thawing.
    Storage
    4 °C,-20 °C
    Storage Comment
    Short term: 4°C. Long term: Store at -20°C. Avoid freeze-thaw cycles.
  • Target
    LCP2 (Lymphocyte Cytosolic Protein 2 (SH2 Domain Containing Leukocyte Protein of 76kDa) (LCP2))
    Alternative Name
    LCP2 / SLP-76 (LCP2 Products)
    Synonyms
    AI323664 antibody, BB161688 antibody, SLP-76 antibody, SLP76 antibody, twm antibody, Slp76 antibody, lymphocyte cytosolic protein 2 antibody, Lcp2 antibody, LCP2 antibody
    Background
    Name/Gene ID: LCP2

    Synonyms: LCP2, 76 kDa tyrosine phosphoprotein, Lymphocyte cytosolic protein 2, SLP-76, SLP-76 tyrosine phosphoprotein, SLP76
    Gene ID
    3937
    UniProt
    Q13094
    Pathways
    TCR Signaling, Fc-epsilon Receptor Signaling Pathway
You are here:
Support